Cases of influenza are being reported in parts of the U.S. as the COVID-19 pandemic continues. While a vaccine is not yet available for COVID-19, there is a vaccine available to prevent influenza.
Nov 25, 2020
0
3
DEAR MAYO CLINIC: My 5-year-old son is afraid of needles. He cries and fusses anytime we have to visit the doctor. When it's time for an immunization or vaccination, he squirms and screams, and he has to be held down. Afterward ...
Nov 19, 2020
0
2
For people who have heart disease, getting a flu shot greatly reduces the risk of dying or developing serious heart-related complications, a new analysis shows.
Nov 18, 2020
0
4
People with heart disease can receive either the high-dose or standard-dose flu vaccines for protection from heart or lung-related deaths or hospitalizations, according to late breaking research presented today at the American ...
Nov 17, 2020
0
2
Misunderstandings about flu vaccines have existed for decades, leading to vaccine mistrust and lower-than-ideal vaccination rates. Now that a coronavirus vaccine appears to be close, experts are concerned that the lack of ...
Nov 13, 2020
0
4
Flu season is getting underway in the U.S. while the COVID-19 pandemic continues to surge in some areas. Both the flu and COVID-19 are respiratory illness that are highly contagious, but they are caused by different viruses. ...
Nov 12, 2020
0
1
We've been dealing with the coronavirus for months. And now the dreaded flu season is upon us. Is it possible that both viruses could infect your body at once?
Nov 11, 2020
0
4
The American Heart Association, the leading voluntary health organization devoted to a world of longer, healthier lives, is helping to keep families and communities safe from the flu by providing facts, resources and encouraging ...
Nov 11, 2020
0
2
The United States could be the first country to launch one of the most ambitious vaccine operations in history: distributing and administering up to 600 million doses of a COVID-19 vaccine in just a few months.
Nov 11, 2020
0
4
German biotech company BioNTech and US pharmaceutical Pfizer announced on Monday promising early results from their phase 3 clinical trial for a vaccine against SARS-CoV-2, the virus that causes COVID-19.
Nov 10, 2020
0
3
